| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 191 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 378 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 473 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 550 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 574 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 591 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 609 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 611 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 777 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 837 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 1463 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 2915 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 3987 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 5072 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 6935 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 7157 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 7198 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 10270 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 10913 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 10957 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 10981 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 12980 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 13945 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 17506 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 17580 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 18173 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 21035 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 22576 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 23131 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 24065 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 24431 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 25804 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 27211 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 28474 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 29247 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 33673 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 34200 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 47322 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 47620 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 48241 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49457 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 49930 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51334 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51850 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 51993 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52039 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 52123 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54234 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 54831 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 56164 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 62809 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 70795 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 73736 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 75856 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 80327 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 128116 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 133645 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 4-hydroxyphenylacetic acid | 139343 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|